Cargando…

Molecular subtyping of ependymoma and prognostic impact of Ki-67

Although ependymomas (EPNs) have similar histopathology, they are heterogeneous tumors with diverse immunophenotypes, genetics, epigenetics, and different clinical behavior according to anatomical locations. We reclassified 141 primary EPNs from a single institute with immunohistochemistry (IHC) and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Ka Young, Lee, Kwanghoon, Shim, Yumi, Park, Jin Woo, Kim, Hyunhee, Kang, Jeongwan, Won, Jae Kyung, Kim, Seung-Ki, Phi, Ji Hoon, Park, Chul-Kee, Chung, Chun-Kee, Yun, Hongseok, Park, Sung-Hye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752536/ https://www.ncbi.nlm.nih.gov/pubmed/34812989 http://dx.doi.org/10.1007/s10014-021-00417-y

Ejemplares similares

Sporadic and Lynch syndrome-associated mismatch repair-deficient brain tumors
por: Kim, Hyunhee, et al.
Publicado: (2021)

MYB/MYBL1::QKI fusion-positive diffuse glioma
por: Suh, Ye Yoon, et al.
Publicado: (2023)

ZFTA‐YAP1 fusion‐positive ependymoma can occur in the spinal cord: Letter to the editor
por: Lim, Ka Young, et al.
Publicado: (2021)

The prognostic significance of p16 expression pattern in diffuse gliomas
por: Park, Jin Woo, et al.
Publicado: (2021)

Ki-67 and breast cancer prognosis: does it matter if Ki-67 level is examined using preoperative biopsy or postoperative specimen?
por: Choi, Soon Bo, et al.
Publicado: (2022)

Genomic profiles of IDH-mutant gliomas: MYCN-amplified IDH-mutant astrocytoma had the worst prognosis
por: Lee, Kwanghoon, et al.
Publicado: (2023)

Macrophagic myofasciitis and subcutaneous pseudolymphoma caused by aluminium adjuvants
por: Kim, Hyunhee, et al.
Publicado: (2020)

Adult WHO grade II ependymomas: is Ki67 a sex-specific proliferation marker?
por: Baig Mirza, Asfand, et al.
Publicado: (2021)

The impact of pathologic differentiation (well/poorly) and the degree of Ki-67 index in patients with metastatic WHO grade 3 GEP-NECs
por: Kim, Hee Kyung, et al.
Publicado: (2017)

Methylation-based Subclassifications of Embryonal Tumor with Multilayered Rosettes in Not Just Pediatric Brains
por: Kim, Eric Eunshik, et al.
Publicado: (2023)

Ki-67 as a Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
por: Kim, Kwan Il, et al.
Publicado: (2014)

Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis
por: Keam, Bhumsuk, et al.
Publicado: (2011)

Interobserver Variability of Ki-67 Measurement in Breast Cancer
por: Chung, Yul Ri, et al.
Publicado: (2016)

Overcoming Chemoresistance of Pediatric Ependymoma by Inhibition of STAT3 Signaling
por: Phi, Ji Hoon, et al.
Publicado: (2015)

Ki-67 labeling index as a prognostic marker in advanced stomach cancer
por: Seo, Sang Hyuk, et al.
Publicado: (2019)

Toxic leukoencephalopathy with axonal spheroids caused by chemotherapeutic drugs other than methotrexate
por: Lim, Ka Young, et al.
Publicado: (2022)

NPM1 as a potential therapeutic target for atypical teratoid/rhabdoid tumors
por: Phi, Ji Hoon, et al.
Publicado: (2019)

Clinical Significance of Ki-67 Labeling Index in Pituitary Macroadenoma
por: Paek, Kyung-Il, et al.
Publicado: (2005)

Postoperative radiotherapy for ependymoma
por: Jung, Jinhong, et al.
Publicado: (2012)

Expression of Cyclooxygenase-2, p53 and Ki-67 in Gastric Cancer
por: Joo, Young-Eun, et al.
Publicado: (2006)

Risk Factors Associated with Discordant Ki-67 Levels between Preoperative Biopsy and Postoperative Surgical Specimens in Breast Cancers
por: Kim, Hyung Sun, et al.
Publicado: (2016)

Expression of p53 protein, PCNA, and Ki-67 in osteosarcomas of bone.
por: Park, H. R., et al.
Publicado: (1995)

VEGF and Ki-67 Overexpression in Predicting Poor Overall Survival in Adenoid Cystic Carcinoma
por: Park, Seongyeol, et al.
Publicado: (2016)

The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes
por: Stathopoulos, George P., et al.
Publicado: (2014)

Ki-67 as a prognostic marker according to breast cancer molecular subtype
por: Soliman, Nahed A., et al.
Publicado: (2016)

Pathological Classification of the Intramedullary Spinal Cord Tumors According to 2021 World Health Organization Classification of Central Nervous System Tumors, a Single-Institute Experience
por: Park, Sung-Hye, et al.
Publicado: (2022)

Ki-67 and p53 expression as a predictive marker for early postoperative recurrence in pancreatic head cancer
por: Kim, Hohyun, et al.
Publicado: (2015)

Immunohistochemical Expression of p27(Kip1), p57(Kip2), Cyclin D1, Nestin, and Ki-67 in Ependymoma
por: Iqneibi, Shahad, et al.
Publicado: (2022)

Prognostic Value of Immunohistochemical Staining of p53, bcl-2, and Ki-67 in Small Cell Lung Cancer
por: Paik, Kwang Hyun, et al.
Publicado: (2006)

Preoperative prediction of Ki-67 and p53 status in meningioma using a multiparametric MRI-based clinical-radiomic model
por: Moon, Chung-Man, et al.
Publicado: (2023)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

Distinguishing Low-Risk Luminal A Breast Cancer Subtypes with Ki-67 and p53 Is More Predictive of Long-Term Survival
por: Lee, Se Kyung, et al.
Publicado: (2015)

Aggressive Supratentorial Ependymoma, RELA Fusion-Positive with Extracranial Metastasis: A Case Report
por: Kim, Seong-Ik, et al.
Publicado: (2017)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Primary renal well-differentiated neuroendocrine tumors: report of six cases with an emphasis on the Ki-67 index and mitosis
por: Kim, Bohyun, et al.
Publicado: (2019)

Ki67 index in intrinsic breast cancer subtypes and its association with prognostic parameters
por: Hashmi, Atif Ali, et al.
Publicado: (2019)

MCM6 versus Ki-67 in diagnosis of luminal molecular subtypes of breast cancers
por: Sadeghian, Dorsay, et al.
Publicado: (2022)

Prognostic relevance of the Ki-67 proliferation index in patients with mantle cell lymphoma
por: Jeong, Tae-Dong, et al.
Publicado: (2016)

Ki67 Antigen as a Predictive Factor for Prognosis of Sinonasal Mucosal Melanoma
por: Kim, Dong-Kyu, et al.
Publicado: (2008)

A comparison of Ki-67 counting methods in luminal Breast Cancer: The Average Method vs. the Hot Spot Method
por: Jang, Min Hye, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v5nhp92janipk7kiamqhhgqq1e